THE Seventh EUROSYMPOSIUM ON HEALTHY AGEING : November 2024.
  • Home
  • Program (2024)
  • Program (2022)
  • Abstracts
  • Registration
  • Declarations
  • Sponsoring
  • Previous EHA conferences
  • How to organize clinical trials on longevity
  • Declaration (Old)
Mario D. Cordero obtained his PhD at the University of Sevilla, where he worked in the implication of NLRP3-inflammasome in different pathologies such as chronic pain, psychiatric disorder and cardiovascular diseases. Then, he was postdoctoral fellow at
the University of Granada. During this postdoctoral period, he started to study the implication of NLRP3 in cardiac and metabolic aging and the potential anti-aging effect of NLRP3 inhibitors. His actual research focusses on the role of the new inflammasomes in other aspect of aging and age-related diseases such as age-dependent loss of ovary reserve and how these could be involved in healthspan and lifespan. Other aspect of his research are about the effect of hypercaloric diets during aging and the inflammasomes.
Powered by Create your own unique website with customizable templates.
  • Home
  • Program (2024)
  • Program (2022)
  • Abstracts
  • Registration
  • Declarations
  • Sponsoring
  • Previous EHA conferences
  • How to organize clinical trials on longevity
  • Declaration (Old)